Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 112 (2) , 335-357
- https://doi.org/10.1016/j.pharmthera.2005.04.011
Abstract
No abstract availableKeywords
This publication has 367 references indexed in Scilit:
- Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampusNeuropharmacology, 2005
- Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injuryPublished by Elsevier ,2003
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Inflammatory processes in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- Reactive Oxygen Species Up-Regulates Cyclooxygenase-2, p53, and Bax mRNA Expression in Bovine Luteal CellsBiochemical and Biophysical Research Communications, 2001
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- Cyclooxygenase‐2 is induced globally in infarcted human brainAnnals of Neurology, 1998
- Prostaglandin E2 facilitates excitatory synaptic transmission in the nucleus tractus solitarii of ratsNeuroscience Letters, 1995
- Characterization of the Promoter of Human Prostaglandin H Synthase-1 GeneBiochemical and Biophysical Research Communications, 1993
- IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effectsLife Sciences, 1985